BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36233527)

  • 21. Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction?
    Tomoe H; Yamashita K
    Arab J Urol; 2019 Mar; 17(1):77-81. PubMed ID: 31258947
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
    Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
    Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.
    Chen Y; Ying Z; Xiao Y; Liu Y; Wu S
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():156-161. PubMed ID: 34492610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.
    Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J
    Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
    Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
    Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic Floor Myofascial Pain Might Influence Treatment Outcome of Interstitial Cystitis/Bladder Pain Syndrome: A Prospective Study.
    Yu WR; Chuang FC; Chang WC; Kuo HC
    Pain Physician; 2022 Nov; 25(8):E1315-E1322. PubMed ID: 36375205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation study of new clinical scoring - "Apollo Clinical Scoring system" for bladder pain syndrome/interstitial cystitis and comparison of outcome with standard "O'Leary-Sant score".
    Taneja R; Singh AK; Sharma A; Taneja N; Raheja A
    Int Urogynecol J; 2023 Aug; ():. PubMed ID: 37642668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
    Cervigni M; Nasta L; Schievano C; Lampropoulou N; Ostardo E
    Biomed Res Int; 2019; 2019():9828397. PubMed ID: 31828153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Clorpactin in refractory bladder pain syndrome/interstitial cystitis: a randomized controlled trial.
    Cvach K; Rosamilia A; Dwyer P; Lim Y; DeSouza A; Ow L; Thomas E; Murray C; Leitch A; Schierlitz L
    Int Urogynecol J; 2021 May; 32(5):1177-1183. PubMed ID: 33452887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α.
    Zhang J; Kang J; Wu L
    Turk J Med Sci; 2024; 54(1):26-32. PubMed ID: 38812622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment.
    Yeh HL; Jhang JF; Kuo YC; Kuo HC
    Neurourol Urodyn; 2019 Sep; 38(7):1985-1993. PubMed ID: 31310370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.
    Nickel JC; Moldwin R; Hanno P; Dmochowski R; Peters KM; Payne C; Wein A
    J Urol; 2019 Aug; 202(2):301-308. PubMed ID: 31090511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
    Bosch PC
    J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anesthetic Bladder Hydrodistention Is Superior to Superior Hypogastric Plexus Neurolysis in Treatment of Interstitial Cystitis-bladder Pain Syndrome: A Prospective Randomized Trial.
    El-Hefnawy AS; Makharita MY; Abed A; Amr YM; Salah El-Badry M; Shaaban AA
    Urology; 2015 May; 85(5):1039-1044. PubMed ID: 25917730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.